Grace & White’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Grace & White's NVO Position: Q3 2026 in Review
Grace & White held its Novo Nordisk (NVO) position steady in Q3 2026 at 29,000 shares worth $1.1M. The position accounts for 0.18% of the portfolio, ranked #84.
Grace & White first reported a position in NVO in Q1 2023 and has held it in 15 quarters since. The position peaked at $4.24M in Q1 2024. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Grace & White held 29,000 shares of Novo Nordisk worth $1.1M as of Q3 2026.
- Grace & White left its Novo Nordisk share count unchanged in Q3 2026.
- Novo Nordisk made up 0.18% of Grace & White's portfolio in Q3 2026, its #84 holding.
- Grace & White first reported a position in Novo Nordisk in Q1 2023 and has held it in 15 quarters since.
- Grace & White's Novo Nordisk position peaked at $4.24M in Q1 2024.
- 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Grace & White's 13F filing for Q3 2026, filed 23 Oct 2026.